We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Grn3.0
Greens Powder Research
Mostly mechanism / observational
16 peer-reviewed studies
What the evidence says
Mostly mechanism / observational
Most Greens Powder studies are mechanism or observational rather than RCTs that measure a clinical effect — keep findings provisional.
Most evidence is from medium-quality randomised trials published 2003–2026 with a typical study size of 51 participants.
Based on 16 studies · 9 RCTs · 1,120 total participants
Confidence
High confidence
By outcome
Micronutrient & carotenoid status
Mostly mechanism / observational6 studies
Safety, contaminants & interactions
Mostly mechanism / observational5 studies
Heart & blood pressure
Mostly mechanism / observational3 studies
Cholesterol & lipids
Mostly mechanism / observational3 studies
Gut microbiome & digestion
Mostly mechanism / observational3 studies
Antioxidant capacity & oxidative stress
Too few graded studies2 studies
Inflammation
Too few graded studies2 studies
Respiratory & lung
Too few graded studies2 studies
Recovery
Too few graded studies2 studies
Weight management
Too few graded studies2 studies
Immune function & cold symptomsOne large trial found about 20% fewer moderate-to-severe cold-symptom days, though total symptom days were unchanged. Other immune findings are surrogate cell-count changes rather than fewer illnesses · 8+ weeks
Too few graded studies1 study
Glucose & metabolic
Too few graded studies1 study
Longevity & aging
Too few graded studies1 study
Kidney & renal health
Too few graded studies1 study
Active research area
6 studies in the last 5 years
200320142026
1RCTn=137 · medium study2012
In plain English: The nearest thing to a test of the substitution claim, though not a head-to-head one: withdrawing fruit and vegetables worsened asthma outcomes, and a lycopene extract nested inside that restricted arm did not compensate.
Wood LG et al. · Am J Clin Nutr (2012)
Low-antioxidant diet group had lower lung function at 14 days and raised CRP by week 14
Low-antioxidant diet group was 2.26 times as likely to have an exacerbation (95% CI 1.04-4.91, p=0.039)
The tomato/lycopene extract arm was NESTED INSIDE the low-antioxidant-diet group, so this is not a head-to-head food-versus-extract randomisation — and a single-carotenoid extract is not a greens powder
In plain English: The largest trial in this literature found about 20% fewer moderate-to-severe cold-symptom days, but no difference in days with any symptoms.
Roll S et al. · Br J Nutr (2011)
Days with moderate or severe cold symptoms: 7.6 vs 9.5 (p=0.023), roughly a 20% relative reduction
Days with ANY cold symptoms: 29.4 vs 30.7 (p=0.616) — null
8 months in hospital healthcare workers with high patient contact
In plain English: The cleanest demonstration that the effect is micronutrient delivery rather than metabolic transformation — vitamins rose sharply while glucose, insulin and lipids were unaffected.
Samman S et al. · J Nutr (2003)
Beta-carotene rose from 0.24 to 1.12 micromol/L and folate from 24.5 to 44.9 nmol/L (both p<0.0001)
Vitamin C, alpha-tocopherol and retinol also rose significantly
Homocysteine fell 8.2 to 7.6 micromol/L (p<0.05) — significant but small in absolute terms
In plain English: Consistency of vitamin K intake matters more than restriction — which is why starting or stopping a greens powder is the risky moment for anyone on warfarin.
Violi F et al. · Medicine (Baltimore) (2016)
Effects on coagulation may be detected only at higher vitamin K intakes (above about 150 mcg/day)
Evidence across studies was conflicting
Authors conclude it is more relevant to maintain a stable dietary pattern, avoiding wide changes in vitamin K intake
In plain English: In overweight and obese adults, eight weeks of an encapsulated fruit and vegetable juice concentrate lowered cholesterol and TNF-alpha — but CRP, the standard inflammation marker, was unchanged.
Williams EJ et al. · Nutrients (2017)
Total cholesterol, LDL cholesterol and plasma TNF-alpha decreased and total lean mass increased, with no change in the placebo group
Plasma CRP was UNCHANGED by the juice concentrate in both the whole group and the high-inflammation subgroup
Effects were larger in the pre-selected subgroup with high baseline inflammation (CRP >= 3.0 mg/mL, n=16)
In plain English: Elemental analysis of algae supplements found lead and arsenic levels the authors judged a considerable public-health risk, alongside iodine high enough to disturb thyroid function.
Reboredo FH et al. · Plants (Basel) (2021)
Lead in several seaweed products posed a considerable risk given possible high daily intake
Arsenic at or above 60 micrograms per gram in arame, one kelp sample and hijiki
Iodine levels in kelp could contribute to excess intake and thyroid dysfunction
In plain English: One of the few trials of an actual modern greens powder found a comprehensively null secondary-outcome panel and a paradoxical increase in epigenetic age.
Robinson LA et al. · Front Nutr (2026)
Horvath epigenetic age paradoxically INCREASED during supplementation; newer clocks showed non-significant favourable trends
Body composition, metabolic biomarkers, dietary intake, breath gases, sleep and psychosocial measures were all unchanged
Gut microbiome alpha diversity unchanged; only two taxa shifted
In plain English: The second and only other human trial of this branded product: its positive finding was that a multi-nutrient product filled nutrient gaps, while microbiome diversity and digestive quality of life were unchanged.
Gonzalez AM et al. · Front Nutr (2026)
Primary positive result was essentially definitional — 2.8 more micronutrient Estimated Average Requirements met versus placebo (p=0.0011), most often vitamins A, C and E
No large, global shift in microbial alpha or beta diversity; only selective enrichment of taxa including Lactiplantibacillus plantarum, Lacticaseibacillus rhamnosus and Bifidobacterium animalis
No significant difference in digestive quality of life between conditions (p=0.777)
In plain English: One of only two human trials of this branded product found no significant improvement in digestive quality of life and only enrichment of the bacteria the product itself contains.
La Monica MB et al. · J Int Soc Sports Nutr (2024)
Enriched Lactobacillus acidophilus and Bifidobacterium bifidum, which the authors concede likely stem from the probiotic species in the product
No significant effect on digestive quality of life (p=0.058), bowel frequency, or stool consistency
Blood count, metabolic and lipid panels unchanged over 4 weeks, supporting tolerability
In plain English: The only evidence synthesis in this category reports effects on selected risk markers, but its health-outcome claims are modelled rather than measured.
Lorenzoni G et al. · J Clin Med (2019)
Reviewed effects on total cholesterol, LDL, homocysteine, systolic blood pressure and BMI
Health-outcome benefits are derived from a Markov simulation model, not measured in trials
Authors hedge that effects 'might be hypothesized to turn into' reductions in disease burden
In plain English: Temporal signal detection in FDA adverse-event reports flagged preliminary hepatic enzyme elevations for AG1 and Nutrafol as emerging signals — a flag for investigation at product-name level, not a confirmed risk.
Farquhar H · Food Chem Toxicol (2026)
CUSUM temporal detection flagged 451 emerging signals, including preliminary hepatic enzyme elevations for AG1 and Nutrafol over 2023-2025
Authors state explicitly that analysis was at PRODUCT-NAME level, not ingredient level, and that signals are flags for further investigation rather than confirmed ingredient-specific risks
Hepatotoxicity signals overall clustered in herbal/botanical and weight-loss products
In plain English: A woman with no prior thyroid disease developed hyperthyroidism three months after starting kelp tablets, resolving fully after she stopped.
Gherbon A et al. · Medicine (Baltimore) (2019)
70-year-old woman with no prior thyroid disease developed tachycardia over 100 bpm, insomnia, anxiety and 6 kg weight loss
Onset roughly three months after starting kelp-containing tablets
Resolved fully after discontinuation plus antithyroid treatment
In plain English: A man with pre-existing chronic kidney disease developed biopsy-confirmed oxalate nephropathy and became dialysis-dependent after regularly drinking spinach and kale smoothies — whole foods, not a powder.
Samra M, Gupta I · Cureus (2024)
54-year-old man with type 2 diabetes and chronic kidney disease presented with unexplained deterioration in renal function